Disruption of Nrf2 exacerbated the damage after spinal cord injury in mice

Journal of Trauma and Acute Care Surgery

Volumn 72, Issue 1, 2012, Pages 189-198

  Mao, Lei ^a   Wang, Han Dong ^a   Wang, Xiao Liang ^a   Tian, Lei ^a   Xu, Jian Ya ^b  

^a NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Inflammation; Knockout; Nrf2; Spinal cord injury

Indexed keywords

CELLOBIOSE QUINONE OXIDOREDUCTASE; DIHYDROPTERIDINE REDUCTASE; GLUTATHIONE TRANSFERASE A1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TRANSCRIPTION FACTOR NRF2; GLUTATHIONE TRANSFERASE; NFE2L2 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN FUNCTION; COLORIMETRY; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DNA BINDING; DURA MATER; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOKED MUSCLE RESPONSE; HINDLIMB; INFLAMMATION; LATENT PERIOD; MALE; MOTOR ACTIVITY; MOTOR PERFORMANCE; MOUSE; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; ANIMAL; ARTICLE; DISEASE MODEL; GEL MOBILITY SHIFT ASSAY; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL CORD;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTATHIONE TRANSFERASE; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MICE; MICE, KNOCKOUT; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84859639831     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e31821bf541     Document Type: Conference Paper

References (25)

1. Choo AM, Liu J, Dvorak M, Tetzlaff W, Oxland TR. Secondary pathology following contusion, dislocation, and distraction spinal cord injuries. Exp Neurol. 2008;212:490-506.
2. Jin W, Wang H, Yan W, et al. Role of Nrf2 in protection against traumatic brain injury in mice. J Neurotrauma. 2009;26:131-139.
3. Lee JM, Johnson JA. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol. 2004;37:139-143.
4. Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997; 236:313-322.
5. Zhao J, Moore AN, Clifton GL, Dash PK. Sulforaphane enhances aquaporin-4 expression and decreases cerebral edema following traumatic brain injury. J Neurosci Res. 2005;82:499-506.
6. Shih AY, Li P, Murphy TH. A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J Neurosci. 2005;25:10321-10335.
7. Wang J, Fields J, Zhao C, et al. Role of Nrf2 in protection against intracerebral hemorrhage injury in mice. Free Radic Biol Med. 2007; 43:408-414.
8. Pomeshchik Y, Malm T, Boman S, Kanninen K, Koistinaho J. Contusion spinal cord injury induces activation of the Nrf2-ARE pathway in the mouse spinal cord. J Neurotrauma. 2009;26:P158.
9. Mao L, Wang H, Qiao L, Wang X. Disruption of Nrf2 enhances the upregulation of nuclear factor-+b activity, tumor necrosis factor-alpha, and matrix metalloproteinase-9 after spinal cord injury in mice. Mediators Inflamm. 2010;2010:238321.
10. Marques SA, Garcez VF, Del Bel EA, Martinez AM. A simple, inexpensive and easily reproducible model of spinal cord injury in mice: morphological and functional assessment. J Neurosci Methods. 2009; 177:183-193.
11. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma. 2006;23:635-659.
12. Ma M, Basso DM, Walters P, Stokes BT, Jakeman LB. Behavioral and histological outcomes following graded spinal cord contusion injury in the C57Bl/6 mouse. Exp Neurol. 2001;169:239-254.
13. McGavern DB, Murray PD, Rivera-Quinones C, Schmelzer JD, Low PA, Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain. 2000;123(Pt 3):519-531.
14. Brown DA, Sawchenko PE. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J Comp Neurol. 2007;502:236-260.
15. Jin W, Wang H, Yan W, et al. Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm. 2008;2008:725174.
16. Miyanji F, Furlan JC, Aarabi B, Arnold PM, Fehlings MG. Acute cervical traumatic spinal cord injury: MR imaging findings correlated with neurologic outcome-prospective study with 100 consecutive patients. Radiology. 2007;243:820-827.
17. Mautes AE, Weinzierl MR, Donovan F, Noble LJ. Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys Ther. 2000;80:673-687.
18. Pineau I, Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol. 2007;500:267-285.
19. Li W, Khor TO, Xu C, et al. Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem Pharmacol. 2008;76:1485-1489.
20. Chen XL, Dodd G, Thomas S, et al. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol. 2006;290:H1862-H1870.
21. van Muiswinkel FL, Kuiperij HB. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders. Curr Drug Targets CNS Neurol Disord. 2005;4:267-281.
22. Kumari Naga K, Panigrahi M, Prakash Babu P. Changes in endogenous antioxidant enzymes during cerebral ischemia and reperfusion. Neurol Res. 2007;29:877-883.
23. Surh YJ, Na HK. NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes Nutr. 2008;2:313-317.
24. Liu GH, Qu J, Shen X. NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim Biophys Acta. 2008;1783:713-727.
25. Thimmulappa RK, Lee H, Rangasamy T, et al. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest. 2006;116:984-995.